Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 4/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | FBP1 | P09467 | 1/20 | 0.30 |
| ▸ | PI4KA | P42356 | 1/20 | 0.30 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.30 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.30 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8363897 | 0.81 | NUDT1 (0.40) | NUDT1FBP1PI4KAPI4K2BPI4K2A | |
| SCHEMBL8363066 | 0.74 | CTSK (0.44) | — | |
| SCHEMBL30718883 | 0.67 | CDK4 (0.49) | — | |
| SCHEMBL8363719 | 0.67 | CTSK (0.46) | — | |
| SCHEMBL13948326 | 0.66 | CTSK (0.44) | — | |
| SCHEMBL8029644 | 0.65 | FBP1 (0.43) | FBP1 | |
| SCHEMBL34470301 | 0.63 | RORC (0.35) | KDM4EALDH1A1HPGDADRA1AHSD17B10 | |
| SCHEMBL22343837 | 0.63 | MAPK8 (0.37) | MAPK14KDM4EALDH1A1HPGDADRA1A | |
| SCHEMBL26607564 | 0.63 | KDM4E (0.39) | NUDT1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL29290171 | 0.62 | HRH3 (0.34) | KDM4EALDH1A1HPGDADRA1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003020721-A1 | PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES | NOVARTIS AG (CH) | 2003-03-13 | — | — | WO | disclosed |